ConductScience.org, home

Paper19592011

Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.

Muratore CS and 3 others. J Surg Res, 2009. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression. Papers, record 19592011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19592011

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.
PubMed
Journal
J Surg Res
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2025-05-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muratore CSChristopher S
2Harty MWMark W
3Papa EFElaine F
4Tracy TF JrThomas F

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory AgentsMajor topic
Biliary AtresiaMajor topic
DexamethasoneMajor topic
Kupffer CellsMajor topic
LiverMajor topic
Animals
Bile Ducts
Cholestasis
Collagen
Cytokines
Decompression, Surgical
Disease Models, Animal
Extracellular Matrix Proteins
Liver Cirrhosis
Macrophages
Male
Neutrophils
Rats

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DK046831NIDDK NIH HHSUnited StatesR01DK046831PubMed and NIH
R01 DK46831NIDDK NIH HHSUnited StatesR01DK046831PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17595823Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia.J Pediatr Surg1995https://conductscience.org/library/papers/7595823PubMed
28632264The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution.J Pediatr Surg1996https://conductscience.org/library/papers/8632264PubMed
310207698The influence of cholangitis on the prognosis of extrahepatic biliary atresia.Eur J Pediatr Surg1999https://conductscience.org/library/papers/10207698PubMed
418436015Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers.Surgery2008https://conductscience.org/library/papers/18436015PubMed
510792959Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction.J Surg Res2000https://conductscience.org/library/papers/10792959PubMed
612632357High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia.J Pediatr Surg2003https://conductscience.org/library/papers/12632357PubMed
711112835Biliary atresia.Semin Pediatr Surg2000https://conductscience.org/library/papers/11112835PubMed
87821959Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1.Immunology1994https://conductscience.org/library/papers/7821959PubMed
92314093A model of reversible obstructive jaundice in the rat.J Surg Res1990https://conductscience.org/library/papers/2314093PubMed
1012852435The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells.J Drug Target2003https://conductscience.org/library/papers/12852435PubMed
1117935230Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia.Hepatology2007https://conductscience.org/library/papers/17935230PubMed
1217706489Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen.J Pediatr Surg2007https://conductscience.org/library/papers/17706489PubMed
137519822Increased expression of intercellular adhesion molecules in biliary atresia.Am J Pathol1994https://conductscience.org/library/papers/7519822PubMed
1410547847Primer3 on the WWW for general users and for biologist programmers.Methods Mol Biol2000https://conductscience.org/library/papers/10547847PubMed
159339941A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers.Ann Surg1997https://conductscience.org/library/papers/9339941PubMed
1611241420CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis.J Pathol2001https://conductscience.org/library/papers/11241420PubMed
1711150442Immunosuppression as adjuvant therapy for biliary atresia.J Pediatr Surg2001https://conductscience.org/library/papers/11150442PubMed
181375180Intrahepatic bile duct loss in biliary atresia despite portoenterostomy: a consequence of ongoing obstruction?Gastroenterology1992https://conductscience.org/library/papers/1375180PubMed
199247243The improved outlook for biliary atresia with corticosteroid therapy.J Pediatr Surg1997https://conductscience.org/library/papers/9247243PubMed
2016410116Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy.J Pediatr Surg2006https://conductscience.org/library/papers/16410116PubMed

See all 25 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
40445412Development and validation of a prediction model for cholangitis after percutaneous transhepatic cholangioscopic lithotripsy.Clin Exp Med2025https://conductscience.org/library/papers/40445412PubMed
38912031Delphi Method Analysis and Consensus of Prevalent Distinctive Practices for Biliary Atresia Management after Kasai Portoenterostomy.J Indian Assoc Pediatr Surg2024https://conductscience.org/library/papers/38912031PubMed
24838399Hepatocytes buried in the cirrhotic livers of patients with biliary atresia proliferate and function in the livers of urokinase-type plasminogen activator-NOG mice.Liver Transpl2014https://conductscience.org/library/papers/24838399PubMed
21468628Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion.Inflammation2012https://conductscience.org/library/papers/21468628PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19592011

GET https://conductscience.org/api/papers/v1/19592011/references?page=2